Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 11/20 | 0.63 |
| ▸ | PRSS1 | P07477 | 11/20 | 0.63 |
| ▸ | PRSS2 | P07478 | 11/20 | 0.63 |
| ▸ | PRSS3 | P35030 | 11/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26324738 | 0.83 | F2 (0.53) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL26324734 | 0.82 | F2 (0.51) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL26324736 | 0.82 | F2 (0.51) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL20447060 | 0.80 | F2 (0.55) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL20447036 | 0.80 | F2 (0.55) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL20447034 | 0.80 | F2 (0.55) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL26324757 | 0.77 | F2 (0.44) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL22699663 | 0.74 | F2 (0.68) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL22634996 | 0.73 | F2 (0.61) | F2PRSS1PRSS2PRSS3HTT | |
| SCHEMBL22634995 | 0.73 | F2 (0.61) | F2PRSS1PRSS2PRSS3HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | WILLIAM MARSH RICE UNIVERSITY (US) | 2023-09-26 | — | — | US | disclosed |
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | WILLIAM MARSH RICE UNIVERSITY (US) | 2023-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | PNMT, NCL, NPM1 | F2 3231/4885PRSS1 4869/4885PRSS2 4452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.